Abbott Laboratories
NYSE:ABT
Net Margin
Abbott Laboratories
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Net Margin Comparison
Abbott Laboratories Competitors
Country | US |
Market Cap | 185.4B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 132.1B USD |
Net Margin |
27%
|
Country | US |
Market Cap | 128B USD |
Net Margin |
15%
|
Country | IE |
Market Cap | 106.9B USD |
Net Margin |
13%
|
Country | US |
Market Cap | 106.9B USD |
Net Margin |
11%
|
Country | US |
Market Cap | 67.6B USD |
Net Margin |
6%
|
Country | DE |
Market Cap | 59.2B EUR |
Net Margin |
7%
|
Country | US |
Market Cap | 53.3B USD |
Net Margin |
23%
|
Country | US |
Market Cap | 53.1B USD |
Net Margin |
15%
|
Country | CN |
Market Cap | 345B CNY |
Net Margin |
33%
|
Country | US |
Market Cap | 41B USD |
Net Margin |
23%
|
Profitability Report
View the profitability report to see the full profitability analysis for Abbott Laboratories.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Abbott Laboratories's most recent financial statements, the company has Net Margin of 14%.